The relationship of large city out-of-hospital cardiac arrests and the prevalence of COVID-19.
The relationship of large city out-of-hospital cardiac arrests and the prevalence of COVID-19.
复制标题
DOI:
10.1016/j.eclinm.2021.100815
复制
发表时间:
2021-04
影响因子:
15.1
通讯作者:
Writing group on behalf of the Metropolitan EMS Medical Directors Global Alliance
中科院分区:
文献类型:
--
作者:
McVaney KE;Pepe PE;Maloney LM;Bronsky ES;Crowe RP;Augustine JJ;Gilliam SO;Asaeda GH;Eckstein M;Mattu A;Fumagalli R;Aufderheide TP;Osterholm MT;Writing group on behalf of the Metropolitan EMS Medical Directors Global Alliance
Though variable, many major metropolitan cities reported profound and unprecedented increases in out-of-hospital cardiac arrest (OHCA) in early 2020. This study examined the relative magnitude of those increases and their relationship to COVID-19 prevalence. EMS (9-1-1 system) medical directors for 50 of the largest U.S. cities agreed to provide the aggregate, de-identified, pre-existing monthly tallies of OHCA among adults (age >18 years) occurring between January and June 2020 within their respective jurisdictions. Identical comparison data were also provided for corresponding time periods in 2018 and 2019. Equivalent data were obtained from the largest cities in Italy, United Kingdom and France, as well as Perth, Australia and Auckland, New Zealand. Significant OHCA escalations generally paralleled local prevalence of COVID-19. During April, most U.S. cities (34/50) had >20% increases in OHCA versus 2018–2019 which reflected high local COVID-19 prevalence. Thirteen observed 1·5-fold increases in OHCA and three COVID-19 epicenters had >100% increases (2·5-fold in New York City). Conversely, cities with lesser COVID-19 impact observed unchanged (or even diminished) OHCA numbers. Altogether (n = 50), on average, OHCA cases/city rose 59% during April (p = 0·03). By June, however, after mitigating COVID-19 spread, cities with the highest OHCA escalations returned to (or approached) pre-COVID OHCA numbers while cities minimally affected by COVID-19 during April (and not experiencing OHCA increases), then had marked OHCA escalations when COVID-19 began to surge locally. European, Australian, and New Zealand cities mirrored the U.S. experience. Most metropolitan cities experienced profound escalations of OHCA generally paralleling local prevalence of COVID-19. Most of these patients were pronounced dead without COVID-19 testing. No funding was involved. Cities provided de-identified aggregate data collected routinely for standard quality assurance functions.
登录
查看更多内容
影响因子:
--
作者:
Hranjec T;Estreicher M;Rogers B;Kohler L;Solomon R;Hennessy S;Cibulas M;Hurst D;Hegazy M;Lee J;Perez D;Doctor N;Kiffin C;Pigneri D;LaGuardia H;Shaw K;Arenas J;Rosenthal A;Katz RS;Sawyer RG;Pepe PE
通讯作者:
Pepe PE
影响因子:
24
作者:
Chan, Paul S.;Girotra, Saket;McNally, Bryan
通讯作者:
McNally, Bryan
影响因子:
11.8
作者:
Qin, Chuan;Zhou, Luoqi;Tian, Dai-Shi
通讯作者:
Tian, Dai-Shi
影响因子:
158.5
作者:
Ackermann, Maximilian;Verleden, Stijn E.;Jonigk, Danny
通讯作者:
Jonigk, Danny
影响因子:
--
作者:
Pepe PE;Aufderheide TP;Lamhaut L;Davis DP;Lick CJ;Polderman KH;Scheppke KA;Deakin CD;O'Neil BJ;van Schuppen H;Levy MK;Wayne MA;Youngquist ST;Moore JC;Lurie KG;Bartos JA;Bachista KM;Jacobs MJ;Rojas-Salvador C;Grayson ST;Manning JE;Kurz MC;Debaty G;Segal N;Antevy PM;Miramontes DA;Cheskes S;Holley JE;Frascone RJ;Fowler RL;Yannopoulos D
通讯作者:
Yannopoulos D